# Cerebrolysin

> Cerebrolysin is a proprietary preparation of low molecular weight peptides and free amino acids enzymatically derived from purified porcine brain protein. Developed decades ago, it has been used in some countries mainly in stroke, traumatic brain injury, and dementia care, though it lacks FDA approval and is not licensed for use in the United States. Its formulation is intended to mimic the combined activity of multiple endogenous neurotrophic factors rather than a single defined peptide sequence. A substantial body of published clinical research exists, primarily from outside North America, with mixed conclusions regarding effect size and methodological quality. It is typically administered by intramuscular or intravenous injection in clinical settings.

- URL: https://www.lifeconverted.com/peptides/cerebrolysin
- Primary category: Cognitive & Neuro
- Effectiveness rank: #6 in Healing & Recovery; #1 in Cognitive & Neuro
- Evidence level: Well studied
- Route: Intramuscular (Typically given by intramuscular or intravenous injection in clinical settings; this profile reflects intramuscular administration.)
- Dose range: 500-2,150 mg
- Dose tiers: low 500 mg; moderate 1075 mg; high 2150 mg
- Half-life: As a mixture of small peptides and amino acids, Cerebrolysin does not have a single defined half-life; its components are generally metabolized within a few hours.
- Timing: Morning
- Cycle: 10-20 consecutive days on, 8-12 weeks or longer off (Clinical protocols described in the literature typically use defined treatment courses rather than continuous daily administration; there is no standardized research-grade cycling schedule outside supervised clinical use.)
- Storage: Store unopened ampoules refrigerated (2-8°C), protected from light; do not freeze. Use opened ampoules promptly and discard any unused solution.

## Mechanism of action

Cerebrolysin is proposed to exert multimodal effects on the central nervous system by mimicking the actions of neurotrophic factors such as BDNF, nerve growth factor, and glial cell line-derived neurotrophic factor, supporting neuronal survival and synaptic plasticity. It has also been studied for anti-inflammatory and antioxidant activity within neural tissue, along with potential modulation of amyloid-related processes in preclinical models. Because it is a mixture rather than a single defined compound, isolating one mechanism of action is not straightforward.

## Reported benefits

- Studied for supporting cognitive recovery after ischemic stroke
- Explored as an adjunct in traumatic brain injury rehabilitation research
- Investigated for symptomatic support in vascular and Alzheimer's-type dementia
- Proposed neurotrophic and neuroprotective properties in preclinical models
- Reported anti-inflammatory activity in some neural tissue studies

## Reported side effects

- Injection site pain or irritation
- Dizziness or agitation reported in some clinical studies
- Rare hypersensitivity reactions
- Gastrointestinal discomfort in some users
- Limited safety data outside supervised clinical settings

## Common protocols

- Defined multi-week treatment courses followed by extended breaks, as described in published clinical studies
- Administration on consecutive weekdays with breaks in some cited protocols

## Stacking notes

Sometimes discussed alongside other neurotrophic-focused peptides in research contexts; concurrent use with other injectable compounds has not been formally studied.

---

Educational information only, not medical advice. Full disclaimer: https://www.lifeconverted.com/disclaimer